GLPwatch
Trials (2101)
Page 27 of 36.
- Effects of Insulin Glargine and Lixisenatide on the Brain
- Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
- Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
- Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis
- A Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Obese Children Aged 7 to 11 Years
- Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
- Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
- A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants
- Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
- Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
- Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
- A Study of LY3502970 in Participants With Impaired and Normal Liver Function
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Comparison of Body Weight Change Through Different Smeglutide Administration Methods
- A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity
- Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19
- Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
- A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.
- The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms
- Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
- Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
- Exercise and GLP-1 RA on Insulin Secretion
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
- Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program
- Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
- Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
- Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
- Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity
- The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
- A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
- Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight
- Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
- Effects of Exenatide on Hypothalamic Obesity
- A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
- Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
- A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
- A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
- A Study of LY3437943 in Participants With Impaired and Normal Liver Function
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular Risk
- A Study of IBI362 in Participants With Type 2 Diabetes
- A Trial to Demonstrate Bioequivalence Between Two Insulin Degludec/Liraglutide Formulations, B5 and V2 in Healthy Subjects
- Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination
- Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
- Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects